Earnings Feed
Start Free
Home/Filings/4/0001209191-23-016721
4//SEC Filing

Stark David Matthew 4

Accession 0001209191-23-016721

CIK 0000818686other
View on SEC.govCompany Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:14 PM ET

Size

18.0 KB

Accession

0001209191-23-016721

Insider Transaction Report

Form 4
Period: 2023-03-03
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
Stark David Matthew
Exec. VP Chief Legal Officer
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-03-04+13,931→ 16,905.39 total
  • Exercise/Conversion

    Ordinary Shares

    2023-03-05+20,199→ 68,940.39 total
  • Exercise/Conversion

    Restricted Share Units

    2023-03-04−13,931→ 0 total
    → Ordinary Shares (13,931 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2023-03-04+31,836→ 48,741.39 total
  • Award

    Restricted Share Units

    2023-03-03+94,621→ 94,621 total
    → Ordinary Shares (94,621 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2023-03-04−31,836→ 95,509 total
    → Ordinary Shares (31,836 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2023-03-05−20,199→ 40,400 total
    → Ordinary Shares (20,199 underlying)
Footnotes (6)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on March 3, 2023, with 23,655 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 23,656 vesting on March 3, 2027.
  • [F4]Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023.
  • [F5]Restricted share units were granted on March 4, 2022, with 31,836 vested on March 4, 2023, 31,836 vesting on each of March 4, 2024 and March 4, 2025 and 31,837 vesting on March 4, 2026.
  • [F6]Restricted share units were granted on March 5, 2021, with 20,199 vested on each of March 5, 2022 and March 5, 2023, 20,199 vesting on March 5, 2024, and 20,201 vesting on March 5, 2025.

Documents

1 file

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

→
Entity typeother

Related Parties

1
  • filerCIK 0001722360

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:14 PM ET
Size
18.0 KB
View on SEC.gov